• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Inadequate evidence for cognitive training in preventing cognitive decline

byEvelyn NguyenandDeepti Shroff Karhade
December 22, 2017
in Chronic Disease, Neurology, Psychiatry, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In healthy elderly adults, cognitive training enhanced cognitive performance in the area that was trained, but there did not seem to be any effect on adults with mild cognitive impairment (MCI).

2. There was inadequate evidence regarding prevention of dementia or decline in cognition through cognitive training.

Evidence Rating Level: 1 (Excellent)   

Study Rundown: Concerns about cognitive loss due to dementia has stimulated the growth of cognitive training programs that claim to undo some of the effects of aging on the brain.  There is limited information on the effects of these training programs on the start of dementia or cognitive decline.  Therefore, the authors of this systematic review sought to assess the present literature for the effectiveness of cognitive training for prevention of Alzheimer disease and related dementias (ADRD) or cognitive decline.  The authors evaluated 11 trials with adult participants who had normal cognitive abilities or MCI.  The researchers found that cognitive training enhanced cognitive performance for healthy older adults, but only in the domain that was trained.  For example, if memory was trained, memory improved but not reasoning or processing speed.  Cognitive training did not seem to have any effect on adults with MCI. There was inadequate evidence regarding prevention of dementia or decline in cognition through cognitive training.  Therefore, health care providers cannot currently recommend cognitive training for decreasing the risk of dementia or cognitive decline.

A strength of the study is that it provides an updated report of the evidence regarding the use of cognitive training for prevention of dementia or decline in cognition.  Limitations of the study include varied interventions and measurements of outcome, outcomes that tended to evaluate performance on tests rather than overall function, and the possibility of publication bias.

Click to read the study, published in Annals of Internal Medicine

Relevant Reading: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia

RELATED REPORTS

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Decline in gait speed paired with domain-specific cognition decline may be a useful screening assessment for dementia

In-Depth [systematic review]: The authors used EMBASE, the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, and PsycINFO to search for pertinent literature that was published from January 2009 to July 2017.  The authors also manually searched the reference lists of certain articles.  To find articles published prior to 2009, the authors used the Agency for Healthcare Research and Quality (AHRQ) review on prevention of decline in cognition and Alzheimer disease.  Qualifying studies were in English, had an intervention of cognitive training with adult participants who had either normal cognitive abilities or MCI, had ≥6 months of follow-up, and gave outcomes of cognitive performance or dementia.  Studies that had a high risk of bias or that included only participants with dementia were excluded.  Of the 11 qualifying trials, 6 had adult participants with normal cognitive abilities, and 5 had adult participants who had MCI.  Most cognitive trainings for healthy elderly adults were computer based, and most trainings for adults with MCI were given in group sessions.  Compared to attention or inactive controls, evidence of moderate strength suggests that training in a certain area may enhance performance in that particular area for adults with normal cognition.  Evidence of low strength suggests that training does not enhance performance for adults with MCI.  The trials for adults with MCI were not as precise as those for adults with normal cognition.  No adverse events were reported.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive declinedementia
Previous Post

QI initiatives improve antibiotic initiation in bone marrow transplant patients

Next Post

Inadequate evidence for OTC supplements in preventing cognitive decline

RelatedReports

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 17, 2022
Chronic Disease

Decline in gait speed paired with domain-specific cognition decline may be a useful screening assessment for dementia

May 31, 2022
#VisualAbstract: Increased physical activity is a long-term protective factor for dementia
StudyGraphics

#VisualAbstract: Increased physical activity is a long-term protective factor for dementia

May 19, 2022
Next Post
Myeloperoxidase upregulation in epileptogenesis seen on molecular imaging

Inadequate evidence for OTC supplements in preventing cognitive decline

Glioblastoma phenotypes identified on MRI predict molecular behavior

2 Minute Medicine Rewind December 25, 2017

Meeting families, demographic information affect child abuse work-up

Kidney failure risk equation (KFRE) discriminates risk in children with chronic kidney disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Relugolix combination therapy is efficacious for endometriosis-associated pain
  • Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination
  • OPTN and UNOS update policy regarding hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.